Cargando…

The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts

Hepatitis B virus infection results in the appearance of anti-HBc antibodies that normally persist lifelong. We analyzed the course of anti-HBc antibodies overtime, focusing on patients with a permanent loss or fluctuating anti-HBc antibodies. From 120,531 patients tested for anti-HBc antibodies (Ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holtkamp, Caroline, Fiedler, Melanie, Dittmer, Ulf, Anastasiou, Olympia E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877063/ https://www.ncbi.nlm.nih.gov/pubmed/35214596 http://dx.doi.org/10.3390/vaccines10020137

Ejemplares similares

Performance of the LIAISON(®) SARS-CoV-2 Antigen Assay vs. SARS-CoV-2-RT-PCR
por: Fiedler, Melanie, et al.
Publicado: (2021)

Isolated Anti-HBc: Significance and Management
por: MORETTO, Florian, et al.
Publicado: (2020)

Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI
por: Holtkamp, Caroline, et al.
Publicado: (2022)

Antibody response to hepatitis B vaccination in isolated anti-HBc positive subjects
por: Gozdas, Hasan Tahsin
Publicado: (2015)

The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population
por: Hyun, Chul S., et al.
Publicado: (2019)

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
por: Cerva, Carlotta, et al.
Publicado: (2022)

Anti-HBc IgM and anti-delta screening by EIA method.
por: Kim, J. S., et al.
Publicado: (1986)

Over 90% of clinical swabs used for SARS‐CoV‐2 diagnostics contain sufficient nucleic acid concentrations
por: Klingen, Robin L., et al.
Publicado: (2021)

Isolated Anti-HBc and Occult HBV Infection in Dialysis Patients
por: Ramezani, Amitis, et al.
Publicado: (2014)

Prevalence of Anti-HBc Antibodies among HBsAg Negative Individuals and Its Association with Occult Hepatitis B
por: Madhavan, Anitha, et al.
Publicado: (2021)

De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor
por: Bedi, Harjot K., et al.
Publicado: (2021)

Fast Detection of SARS-CoV-2 RNA Directly from Respiratory Samples Using a Loop-Mediated Isothermal Amplification (LAMP) Test
por: Anastasiou, Olympia E., et al.
Publicado: (2021)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

Evaluation of Blood Units with Isolated Anti HBC for the Presence of HBV DNA
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2002)

Sporotrichosis In Immunocompromised Hosts
por: Queiroz-Telles, Flavio, et al.
Publicado: (2019)

Infections in the Immunocompromised Host
por: Bin-Hussain, Ibrahim
Publicado: (2012)

Sepsis in Immunocompromised Hosts
por: Conlon, Christopher
Publicado: (2000)

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment
por: Thümmler, Laura, et al.
Publicado: (2022)

Bullous Scabies in an Immunocompromised Host
por: Wester, James R., et al.
Publicado: (2022)

Beam position for the 2m HBC
por: Perreau, J M, et al.
Publicado: (1964)

Report on the future program for the HBC 200
por: CERN. Geneva. Track Chamber Committee
Publicado: (1975)

Memorandum : HBC 200 Camera Window
por: Stierlin, R G, et al.
Publicado: (1975)

Geometry titles for the 2m HBC
por: Kellner, G
Publicado: (1969)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity
por: Fernández-Rodríguez, Concepción, et al.
Publicado: (2022)

Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
por: Laksananun, Nattinee, et al.
Publicado: (2019)

Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
por: Scheller, Laura, et al.
Publicado: (2021)

Immunocompromised hosts: Infections and biomarkers
por: Kulkarni, Atul P.
Publicado: (2013)

HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017)

Aspergillosis myocarditis in the immunocompromised host
por: Bullis, Sean S., et al.
Publicado: (2019)

Cytomegalovirus pneumonitis in an immunocompromised host
por: Balakrishnan, Rabitha, et al.
Publicado: (2022)

Herpetic zoster folliculitis in the immunocompromised host
por: Shaigany, Sheila, et al.
Publicado: (2015)

Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients
por: Laurenti, R., et al.
Publicado: (2013)

Automatic Measurement of Six Fiducials on HBC 200 Film
por: Hooper, J E
Publicado: (1972)

Evaluation of HBs-Ag and anti-HBc levels in serum and saliva of patients with hepatitis B
por: Gharavi, Matine, et al.
Publicado: (2020)

Test on double pulsing of the 2m HBC
por: Blumenfeld, H, et al.
Publicado: (1970)

Proposals of experiments to be performed with stopping $K^{-}$ in HBC
por: Padua Bubble Chamber and Separator Group, et al.
Publicado: (1962)

Optical constant determination for the 2 meter HBC
por: Bergé, J P
Publicado: (1975)

Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in “Isolated anti-HBc” Antibodies Profile in Central Tunisia
por: Mhalla, Salma, et al.
Publicado: (2016)

2238. Immunogenicity and safety of four- vs. three-standard doses HBV vaccination in HIV-infected adults with isolated anti-HBc antibody
por: Laksananun, Nattinee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ulimf1894qvdbkp8k9b0rptmt1